Reviewer - Alun McCarthy | Adorial Ltd | 6524
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Alun McCarthy

Alun McCarthy
Founder & CEO at Adorial
Wycombe Marsh,
Buckinghamshire, United Kingdom


Alun McCarthy is Founder & CEO at Adorial, Cytopathfinder, Wycombe Marsh in United Kingdom. Adorial Ltd is a virtual drug discovery company using a proprietary in silico genomics platform to identify novel drug targets.

Research Interest

Drug Discovery, Drug Development, Pharmacogenomics, Pharmacogenetics, Biomarkers, Biomarker Discovery, CNS disorders, Cardiovascular Disease, Strategic Leadership, Technical Leadership, Clinical Research, Clinical Trials, Pharmaceutical Industrym, Life Sciences, Clinical Development, Biotechnology, Genomics, Medical Diagnostics

Global Speakers in the subject

Global Experts in the subject